SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
MetaVia Inc. entered into an At The Market (ATM) Offering Agreement on November 6, 2025, and filed a prospectus supplement on July 2, 2026, to offer and sell up to $4,000,000 of common stock shares through Ladenburg Thalmann. This is a classic dilutive equity issuance under Rule 415(a)(4), which creates potential shareholder dilution and is material to investors assessing capital structure and ownership stakes.
View raw filing on EDGAR →The filing discloses an amendment to a Registration Rights Agreement with holders of 50.1% or more of Registrable Securities, extending the Filing Date deadline to 30 calendar days after the Final Closing Date (on or before July 17, 2026). This is a material amendment to a capital-related agreement affecting registration obligations and timing, but does not fit the specific categories of debt issuance, dilutive issuance, or M&A activity. It is clearly financial in nature and material to investors monitoring the company's capital structure and registration timeline.
View raw filing on EDGAR →W. P. Carey consummated a public offering of $350 million in 5.200% Senior Notes due 2036 on July 2, 2026. This is a direct creation of a new financial obligation governed by an indenture with specified terms, interest rate, and maturity date. The company intends to use proceeds to repay existing debt and fund general corporate purposes, which is typical debt issuance disclosure under Item 1.01.
View raw filing on EDGAR →This exhibit presents unaudited pro forma consolidated financial statements reflecting the disposition of certain operating subsidiaries and related business assets for nominal consideration of RMB 1. The document explicitly states the pro forma balance sheet and statement of operations are prepared "as if the Disposition had been consummated" and "as if the Disposition had occurred on January 1, 2025." This is a material disposition/divestiture event that substantially reduces the Company's asset base and operational scope, eliminating all revenue and operating expenses from the disposed subsidiaries. The transaction materially affects the registrant's financial position and future operations.
View raw filing on EDGAR →The filing discloses the dismissal of Ernst & Young LLP as the Company's independent registered public accounting firm effective June 29, 2026, and the concurrent engagement of KPMG LLP as the new auditor. This is a classic auditor change event under Item 4.01. The disclosure confirms no disagreements or reportable events with the departing auditor, and no prior consultations with the incoming auditor on accounting matters, indicating a routine transition rather than one driven by audit disputes.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Alumis Inc.'s 2026 Annual Meeting of Stockholders held on June 30, 2026. The filing presents voting results for two proposals: election of three Class II directors (James B. Tananbaum, Lynn Tetrault, and Zhengbin Yao) and ratification of PricewaterhouseCoopers LLP as independent auditor, with detailed vote tallies for each matter. Shareholder votes on director elections and auditor ratification are material governance events affecting investor assessment of board composition and audit oversight.
View raw filing on EDGAR →Kite Realty Group's operating partnership issued $345 million aggregate principal amount of 3.25% Exchangeable Senior Notes due 2032 on July 2, 2026, pursuant to an Indenture with U.S. Bank Trust Company as trustee. The notes are senior unsecured obligations exchangeable into approximately 11.9 million common shares, with net proceeds of approximately $335.7 million used for debt repayment and share repurchases.
View raw filing on EDGAR →The operating partnership issued $345 million of exchangeable senior notes to qualified institutional buyers under Rule 144A as an unregistered private placement, with the notes exchangeable into approximately 11.9 million common shares at an initial exchange rate of 28.2466 shares per $1,000 principal.
View raw filing on EDGAR →The disclosure centers on the Company's adoption of the 2026 Performance Equity Plan on July 1, 2026, which reserves 33.6 million shares for stock-based awards to employees, executives, and directors. The Board intends to grant performance awards under the Plan to executive officers and named executive officers as incentive compensation. This is a compensatory arrangement disclosure under Item 5.02(e), distinct from an executive departure or appointment.
View raw filing on EDGAR →Gold Resource Corporation shareholders approved the Arrangement Agreement and Plan of Merger with Goldgroup Mining Inc. at a special meeting held on July 2, 2026, with 96,312,452 votes in favor and 4,681,241 votes against. The merger will result in Gold Resource becoming a wholly owned subsidiary of Goldgroup.
View raw filing on EDGAR →Terra Property Trust completed an exchange offer on June 30, 2026, resulting in issuance of $27,156,250 aggregate principal of new 11.00% Senior Secured Notes due July 1, 2027, and entered into a $25 million term loan agreement with Strategic Yieldco on June 29, 2026. Both transactions represent material creation of new direct financial obligations affecting the registrant's capital structure.
View raw filing on EDGAR →MV Oil Trust announced its final quarterly distribution of $6,829,206 ($0.593844 per unit) payable July 24, 2026.
View raw filing on EDGAR →MV Oil Trust's net profits interest terminated on June 30, 2026, triggering dissolution of the Trust. The trustee notified the NYSE on July 2, 2026 of the Trust's intention to voluntarily withdraw listing, with delisting expected prior to market open on July 27, 2026, followed by Form 15 deregistration.
View raw filing on EDGAR →This is an at-the-market (ATM) sales agreement dated July 2, 2026, under which NervGen Pharma Corp. authorizes Leerink Partners LLC to sell up to US$50,000,000 of common shares on an ongoing basis. The agreement explicitly permits sales "at market prices" through Nasdaq and other U.S. trading venues (Section 3), with the Company retaining discretion to issue Placement Notices controlling timing and volume. This is a classic dilutive equity issuance arrangement that would materially affect shareholder interests through potential share dilution.
View raw filing on EDGAR →On June 29, 2026, Chiron Real Estate completed the sale of seven inpatient rehabilitation hospital properties for $217.0 million aggregate purchase price, while retaining a 15% ownership interest in the purchasing joint venture. The transaction resulted in an estimated gain on sale of approximately $70.7 million and materially affects the Company's asset base, operations, and financial position.
View raw filing on EDGAR →Duke Energy Carolinas reached a partial settlement with the North Carolina Public Staff on a rate case filed November 20, 2025, resolving certain operating costs, capital expenditures, and accounting adjustments while leaving major issues (ROE, capital structure, MYRP capital program, storm recovery) for litigation. The settlement results in a $10 million pre-tax accounting charge in Q2 2026 and reduces the company's requested revenue increase from $1,002 million to $556 million. This is a material regulatory milestone affecting the company's operational and financial trajectory, but does not fit neatly into financial categories (not a restatement, impairment, or debt event) and is best classified as a significant operational/regulatory development.
View raw filing on EDGAR →The Company effected a 1-for-20 reverse stock split through an amendment to its Certificate of Incorporation filed with Delaware on July 2, 2026, materially modifying the rights of security holders.
View raw filing on EDGAR →The exhibit is a formal notice from Grupo Financiero Galicia announcing the payment of the first installment of cash dividends in the amount of Ps. 13,333,257,333.33, approved by the Ordinary Shareholders' Meeting on April 28, 2026, with payment to shareholders registered as of July 6, 2026, effective July 13, 2026. This is a material dividend distribution event that would affect investor assessment of capital returns.
View raw filing on EDGAR →The exhibit is a formal notice of cash dividend payment by Grupo Financiero Galicia S.A. declaring a total dividend of Ps. 39,999,772,000 payable in three equal installments beginning July 1, 2026, at Ps. 8.30084132575628 per share. This is a material distribution to shareholders approved by the Board on June 30, 2026, in compliance with the April 28, 2026 shareholders' meeting resolution.
View raw filing on EDGAR →Itaú Unibanco won a competitive bidding process to renew a five-year contract providing payment and payroll services to approximately 670,000 employees and suppliers of the State of Minas Gerais, with a total investment of BRL 2.188 billion recorded as an intangible asset. This is a material operational/commercial milestone — a significant contract renewal with a large government entity — but does not fit the specific event categories (not M&A, not a financial obligation in the debt sense, not a restructuring). The operational domain is clear, making `operational_other` more appropriate than `other_material`.
View raw filing on EDGAR →The press release announces the successful completion of IperionX's acquisition of the Camden critical mineral, property, and infrastructure assets located adjacent to the Titan Project in Tennessee. This is a material acquisition that consolidates and expands the company's landholdings and mineral rights, combining ultra-high-grade surface stockpiles with established infrastructure and pre-stripped mineralization. The deal is explicitly described as "transformational" and "strategically important" to the company's development pathway.
View raw filing on EDGAR →The filing discloses Amendment No. 7 to the CEO's employment agreement, which extends the contract term and, more substantively, approves salary increases for Selwyn Joffe from $828,256 to $902,799 (effective June 26, 2026) and further to $984,050 (effective April 1, 2027). While the amendment also extends the employment term, the principal disclosed action centers on the compensatory arrangement—the salary increases approved by the Board and Compensation Committee. This is a material executive compensation disclosure under Item 1.01.
View raw filing on EDGAR →FTAI Infrastructure Inc. entered into a Bridge Loan Credit Agreement on July 1, 2026, creating a new $230.0 million secured debt facility. The bridge loan was used to repay maturing Taxable Series 2024B Bonds and fund debt service reserves, representing a material new financing arrangement affecting the registrant's capital structure and liquidity.
View raw filing on EDGAR →The filing explicitly discloses a material cybersecurity incident under Item 1.05: a ransomware attack on a third-party law firm resulted in unauthorized access to sensitive Company-related borrower data including names, dates of birth, addresses, and Social Security numbers. The Company determined the incident material on June 29, 2026 "in light of the volume and sensitivity of the information involved," triggering mandatory disclosure and notification obligations under federal and state law.
View raw filing on EDGAR →BridgeBio entered into an Investment Agreement on July 1, 2026, under which Sixth Street Partners and HealthCare Royalty (a KKR affiliate) purchased $1 billion in Series A Cumulative Convertible Participating Preferred Stock, convertible into approximately 6.78 million common shares at an initial conversion price of $137.79 per share. This substantial private placement, relying on Section 4(a)(2) exemption, materially dilutes existing shareholders' ownership and voting power while strengthening the company's balance sheet.
View raw filing on EDGAR →The filing discloses both a director departure (David Sambur's resignation effective July 2, 2026) and a director appointment (Christine Duffy's appointment to fill the vacancy). While both events occur, the principal disclosed action centers on the appointment of Ms. Duffy to the board, with her qualifications, compensation terms, and indemnification agreement detailed. The departure is presented as a mechanical consequence of Apollo Investors' reduced designation rights following their public offering. The appointment of a qualified director with significant hospitality industry experience is the substantive event requiring investor attention.
View raw filing on EDGAR →Bank7 Corp. entered into a definitive Stock Purchase Agreement on July 1, 2026, to acquire approximately 71% of Century Financial Services Corporation for $68.0 million in cash, creating a combined organization with approximately $3.4 billion in total assets. The transaction is subject to court approval and regulatory conditions and represents a material, franchise-enhancing acquisition extending Bank7's geographic footprint into New Mexico.
View raw filing on EDGAR →T. Rowe Price OHA Select Private Credit Fund entered into an Indenture on July 2, 2026, relating to the issuance of $400 million in aggregate principal amount of 6.500% Notes due 2031, with net proceeds of approximately $391.4 million to be used for investments, debt reduction, and general corporate purposes.
View raw filing on EDGAR →The filing discloses the departure of Cortney Caudill as Senior Vice President, Chief Operating Officer effective June 30, 2026. The principal disclosed action is a named executive officer leaving her role. While the filing mentions "an update to its senior management structure," the substantive disclosure centers on Ms. Caudill's departure, making this an exec_departure event. The COO position is material to investor assessment of company leadership.
View raw filing on EDGAR →This press release announces a clinical development milestone: the first patients dosed in a Phase 1/2a trial of MP0712, a Radio-DARPin candidate targeting DLL3 in small cell lung cancer and other neuroendocrine tumors. The disclosure is a material operational/clinical event for a clinical-stage biotech company, marking progress in a lead program under a strategic partnership with Orano Med. While not a discrete M&A transaction, executive change, or financial event, it represents a significant advancement in the company's pipeline that would affect a reasonable investor's assessment of development progress and value.
View raw filing on EDGAR →PennantPark Investment Corporation announced its monthly distribution of $0.08 per share for July 2026, comprised of a $0.04 base dividend and $0.04 supplemental dividend, payable on August 3, 2026. This is a routine but material disclosure of a dividend distribution to shareholders, which is a standard event for a business development company and would affect investor assessment of capital returns.
View raw filing on EDGAR →The filing announces PennantPark Floating Rate Capital Ltd.'s monthly distribution of $0.0833 per share for July 2026, comprised of an $0.08 base dividend and $0.0033 supplemental dividend, payable on August 3, 2026. This is a routine but material disclosure of a dividend distribution to shareholders, consistent with the company's status as a regulated investment company (RIC) that regularly distributes income to stockholders.
View raw filing on EDGAR →A rock mass movement at the Barnat pit of Canadian Malartic on July 1, 2026, has caused temporary suspension of mining operations and is expected to reduce production by 60,000–80,000 ounces of gold in H2 2026 and up to 150,000 ounces per year in 2027–2028. This is a material operational disruption at a key asset (Canadian Malartic is OR Royalties' cornerstone asset, on which it holds a 5% NSR royalty), affecting production guidance and the company's cash flows. While the company states its overall guidance remains unchanged, the underlying operational impact is significant and material to investors.
View raw filing on EDGAR →The 6-K discloses exercise of put options by investors in a September 2025 private placement, requiring the Company to repurchase 1,196,295 Ordinary Shares and 633,931 Pre-Funded Warrants in exchange for 2,114,583 TON tokens and 5,136,459 USDC tokens. While the immediate event is a share repurchase (reducing dilution), the underlying transaction chain originates from the dilutive private placement financing with embedded put rights, which materially affects capital structure and investor rights.
View raw filing on EDGAR →Equinor completed a share capital reduction by cancelling and redeeming 166,058,472 shares, reducing share capital from NOK 6.39 billion to NOK 5.98 billion. This is a return of capital to shareholders through share cancellation, functionally equivalent to a capital distribution. While the mechanism is redemption rather than a cash dividend, it represents a material distribution of value to shareholders and affects the capital structure materially.
View raw filing on EDGAR →The filing discloses a customer win and accelerating product adoption: Nova's WMC™ platform has been selected by a leading global foundry customer for advanced packaging processes, designated as "tool-of-record" following competitive evaluation, with expectations to support multiple production flows and position Nova for further deployment. This is a material operational/commercial milestone reflecting market traction and revenue opportunity, but does not fit the discrete event categories (not M&A, not a financial result, not an executive change). The language emphasizes "rapid growth phase" and "accelerating adoption across several memory and foundry customers," signaling material business development.
View raw filing on EDGAR →monday.com Ltd. furnished proxy statement and notice of annual general meeting scheduled for August 6, 2026, soliciting shareholder votes on director re-elections, approval of a Compensation Policy for Executive Officers and Directors, approval of Co-CEO compensation terms, approval of non-employee director compensation, and auditor re-appointment.
View raw filing on EDGAR →The Company discloses receipt of a Nasdaq compliance notice on March 26, 2026, for failure to meet the minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)), and now reports on July 1, 2026, that it has regained compliance after the closing bid price remained at $1.00 or greater for 10 consecutive business days. This is a material delisting-risk disclosure: the Company faced potential delisting but has now cured the deficiency. The resolution is favorable, but the prior non-compliance and the regulatory process itself are material to investors assessing listing status and trading risk.
View raw filing on EDGAR →Mitesco entered into a $30 million equity line of credit facility with C/M Capital Partners, L.P., allowing the company to draw capital over 36 months by issuing common stock at a 10% discount to market price, subject to a 4.99% beneficial ownership cap. The company issued a $600,000 Convertible Promissory Note as consideration and agreed to register the shares for resale.
View raw filing on EDGAR →Mitesco issued over 4.5 million shares of restricted common stock in unregistered private placements under Regulation D exemptions, including 454,052 shares for Series X Preferred dividends, 3,698,147 shares for Series A Preferred redemptions, 700,000 shares for consulting services, and 400,000 shares as management incentives.
View raw filing on EDGAR →Mitesco granted 200,000 shares of restricted common stock to the CEO and 200,000 shares to the Chairman of the Board as an incentive bonus for the first half of FY2026.
View raw filing on EDGAR →Tony O'Neill, a non-executive Director who served on the Audit & Risk, Sustainability, and Nominations & Governance committees since June 2024, has announced his resignation effective 1 July 2026. This is a clear executive departure disclosure. The announcement explicitly states his intention to resign and his committee memberships, making this a material governance event that would affect a reasonable investor's assessment of board composition and oversight.
View raw filing on EDGAR →This exhibit discloses the completion of a share buyback program in which Wipro Limited extinguished 60 crore (600 million) equity shares, reducing total shares outstanding from 10.50 billion to 9.90 billion shares. The buyback was conducted pursuant to a public announcement dated May 22, 2026, and the tendering period closed June 17, 2026. Share buybacks are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The materiality is evident from the scale: 5.7% of pre-buyback equity capital was retired, affecting the post-buyback shareholding pattern across all investor categories.
View raw filing on EDGAR →The exhibit announces the appointment of Ms. Xiaojing Lu as a director and member of two board committees, effective July 1, 2026. Although the announcement also discloses the concurrent resignation of Ms. Yifang Xu, the principal disclosed action is the appointment of a new director with significant internal operational experience and board committee responsibilities. This is a material governance event affecting board composition.
View raw filing on EDGAR →The exhibit announces completion of an approximately €11.8 million equity raise comprising a €10.65 million equity financing plus €1.1 million from capitalization of bridge loan OID and PIK interest, together with a separate €4 million investment by FOCUS ON NEXT FRONTIER. This represents a material dilutive equity issuance totaling approximately €15.8 million, executed as part of a financial restructuring to strengthen the balance sheet and liquidity position. The involvement of new shareholders (FOCUS) and existing shareholders (Generalitat de Catalunya via IFEM) confirms the issuance of new equity securities.
View raw filing on EDGAR →This is a press release announcing XPENG's vehicle delivery results for June 2026 and Q2 2026 (103,295 units delivered in the quarter). The disclosure of quarterly delivery volumes is a key operational and financial metric for an automotive manufacturer that would materially affect investor assessment of the company's performance and market position. While not a traditional earnings release with full financial statements, delivery results are a material operational metric commonly disclosed by EV manufacturers as a proxy for near-term financial performance.
View raw filing on EDGAR →Lindsay Corporation issued a press release on July 2, 2026 announcing its third quarter fiscal 2026 results ended May 31, 2026, with detailed financial statements including revenues of $160.8 million, operating income of $18.5 million, and diluted EPS of $1.53. The disclosure includes segment results, balance sheet data, and cash flow information, which is the standard format for a quarterly earnings release under Item 2.02.
View raw filing on EDGAR →The Company's Board of Directors declared a quarterly dividend of $625 per share of Series A Cumulative Perpetual Preferred Stock (equivalent to $0.625 per Depositary Share), with record date July 15, 2026 and payment date July 31, 2026. This is a straightforward dividend distribution on preferred stock, disclosed via press release in Item 8.01.
View raw filing on EDGAR →Surf Air Mobility exchanged an existing $46.9 million Senior Secured Convertible Note (issued November 2025) for two new notes: a $16.9 million Senior Secured Convertible Note due 2027 and a $30 million Senior Secured Term Note due 2028, closed July 1, 2026. This restructuring materially alters the company's debt profile, capital structure, and maturity schedule.
View raw filing on EDGAR →The disclosure announces a Phase 3 clinical trial presentation at a major medical conference (ESC Congress 2026) and provides an update on the timing of topline data release (August 2026). This is a material operational/clinical milestone for a development-stage pharmaceutical company, as it signals progress toward potential regulatory approval of TNX-103 for PH-HFpEF. While not a specific event type like earnings release or M&A activity, it represents a significant clinical and strategic development that would affect investor assessment of the company's pipeline advancement.
View raw filing on EDGAR →